EUDA news

The European Union Drugs Agency (EUDA) has today launched its new civil society platform on drugs, a dedicated online space designed to strengthen cooperation with civil society organisations (CSOs) across Europe. Civil society plays a vital role in understanding how drug-related issues affect people and communities in real life. Through their on-the-ground experience and direct engagement with affected populations, CSOs provide essential insights that help ensure that policies and responses are effective, inclusive and meet emerging needs. The new platform provides a structured framework…

Dr Lorraine Nolan, EUDA Executive Director EUDA Executive Director, Dr Lorraine Nolan, addressed the European Parliament Committee on Civil Liberties, Justice and Home Affairs (LIBE) today, setting out the priorities of the EU Justice and Home Affairs Agencies’ Network (JHAAN) for 2026. The EUDA took over the JHAAN presidency from the Fundamental Rights Agency (FRA) on 1 January…

Addressing drug-related challenges in prisons is a key component of wider public health and security efforts. As the drug use experience of the prison population often reflects wider societal trends, responses in these environments play an important role in identifying drug trends and addressing potential drug-related issues. This week, the European Union Drugs Agency (EUDA) brought together experts in Lisbon for a two-day meeting ‘Prison and drugs: increasing the preparedness of prisons to address the drug phenomenon’. The event (17–18 March) took place under the EUDA’s one-year presidency…

The latest findings from the largest European project monitoring illicit drug use through wastewater analysis are released today in Wastewater analysis and drugs — a European multi-city study, published by the Europe-wide SCORE group, in association with the European Union Drugs Agency (EUDA). This year’s findings highlight a marked decline in MDMA residues across the participating cities, alongside strong increases in ketamine and cocaine detections. The project analysed wastewater in 115 European cities from 25 countries (23 EU, Norway + Türkiye) to explore the drug-taking behaviours of…

Ketamine produced legitimately outside the EU to make medicines is increasingly finding its way onto Europe’s illicit drug market, according to a new report published today by the EU Drugs Agency (EUDA). The study, Ketamine in Europe, provides the first comprehensive multi-country intelligence picture of how organised criminal networks are exploiting legitimate pharmaceutical supply chains in Europe and the implications this may have for public health and law enforcement. The report was produced within the framework of the European Multidisciplinary Platform Against Criminal Threats (EMPACT…

Why is it important to consider a gender perspective in the drugs field? What do the data tell us about the main gender differences in drug use and drug-related harms in Europe? Is the gender gap in drug use narrowing among younger generations? How can gender-responsive interventions be implemented in the drugs field?  These are just some of the questions posed in our Frequently asked questions (FAQ): gender and drugs in Europe published today. The new resource provides answers to important questions on gender and drugs, with a particular focus on the European situation…

On World Energy Efficiency Day, we are delighted to announce that the EUDA has been officially registered under the EU Eco-Management and Audit Scheme (EMAS), in recognition of its commitment to reducing its environmental impact. EMAS is the EU voluntary instrument for environmental management and auditing, which allows organisations to evaluate, report on, and continuously improve their environmental performance. Registration is valid for three years and can be renewed following a successful reassessment. Environmental management has been an integral part of our operations for over a…